Vantage Pharma, Biotech & Medtech 2019 in Review
Vantage Pharma, Biotech & Medtech 2019 in Review
From Novartis, Bristol MS meds to new ADCs, here are 2020’s blockbuster drug launches
From Novartis, Bristol MS meds to new ADCs, here are 2020’s blockbuster drug launches
Vantage 2020 Preview – what’s in store for the biopharma sector?
Vantage 2020 Preview – what’s in store for the biopharma sector?
Advancing Glycemic Management in People with Diabetes – report
Advancing Glycemic Management in People with Diabetes
Novartis AG and Pfizer Inc. Compete for a Bigger Share of the Pharmaceuticals Market Reports Technavio
Novartis AG and Pfizer Inc. Compete for a Bigger Share of the Pharmaceuticals Market Reports Technavio
Global Oncology Trends 2019 report
Global Oncology Trends 2019 report
“Η φαρμακευτική αγορά στην Ελλάδα: Γεγονότα και Στοιχεία 2018” Οι αριθμοί δείχνουν ότι βγήκαμε από τα μνημόνια, αλλά όχι από την κρίση
Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! Το Ίδρυμα Οικονομικών και Βιομηχανικών Ερευνών, με τη συνεργασία του Συνδέσμου Φαρμακευτικών Επιχειρήσεων Ελλάδος, παρουσίασε σήμερα … Continue Reading “Η φαρμακευτική αγορά στην Ελλάδα: Γεγονότα και Στοιχεία 2018” Οι αριθμοί δείχνουν ότι βγήκαμε από τα μνημόνια, αλλά όχι από την κρίση
Vantage Report 2018: Research Dragged, but Biotech IPOs and Startups Soared
Vantage Report 2018: Research Dragged, but Biotech IPOs and Startups Soared
Deloitte: 2019 Global life sciences outlook report
Deloitte: 2019 Global life sciences outlook report
The Global Use of Medicine in 2019 and Outlook to 2023
The Global Use of Medicine in 2019 and Outlook to 2023
2019 Trends Brief from PwC
2019 Trends Brief from PwC
New Industry Report Finds Most Orphan Drugs Aren’t Successful
The 2018 Trinity Drug Index
Biopharma in 2019
Biopharma in 2019
»Drug Developments in Prostate Cancer» report
Men’s Health: Drug Developments in Prostate Cancer » report
Potential of First-in-Class Epidiolex for Epilepsy and its Significance in the Advent of Medical Marijuana
Potential of First-in-Class
Epidiolex for Epilepsy and its
Significance in the Advent
of Medical Marijuana
Vantage Pharma, Biotech & Medtech Half-Year Review 2018
The Vantage Half-Year Review 2018 shows that biopharma small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers. Our report … Continue Reading Vantage Pharma, Biotech & Medtech Half-Year Review 2018
